Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide

3,4-dihydroxyphenylacetaldehyde has been researched along with n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide in 1 studies

Compound Research Comparison

Studies
(3,4-dihydroxyphenylacetaldehyde)
Trials
(3,4-dihydroxyphenylacetaldehyde)
Recent Studies (post-2010)
(3,4-dihydroxyphenylacetaldehyde)
Studies
(n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide)
Trials
(n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide)
Recent Studies (post-2010) (n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide)
9905068059

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beausoleil, E; Kong, D; Kotraiah, V; Pallares, D; Toema, D1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide

ArticleYear
Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening.
    Journal of enzyme inhibition and medicinal chemistry, 2013, Volume: 28, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Aldehyde Dehydrogenase, Mitochondrial; Benzamides; Benzodioxoles; Binding Sites; Case-Control Studies; Enzyme Activation; Gene Expression Regulation, Enzymologic; Humans; Ligands; Molecular Docking Simulation; Parkinson Disease; Retinal Dehydrogenase; Small Molecule Libraries; Substantia Nigra; User-Computer Interface

2013